Dr. Anil K. Sood is a leading gynecologic oncologist and scientist internationally recognized for his contributions to the study and treatment of Ovarian Cancer. In this regard, he has served as Vice Chair of Translational Research in the Departments of Gynecologic Oncology and Cancer Biology at The University of Texas MD Anderson Cancer Center , where he has also served as Co-Director of the RNA Interference and Non-Coding RNA Center. In addition, he has directed the Blanton-Davis Multidisciplinary Ovarian Cancer Research Program and co-led the Ovarian Cancer Moon Shot Program. In fact, his research focus has been on Cancer Biology, with emphasis on Angiogenesis, Metastasis and RNAi Therapy.

He has also pioneered the development of new strategies for the delivery of interfering RNA (siRNA) in cancer treatments, achieving significant advances in the creation of targeted therapies for targets previously considered “untreatable”. His research has also addressed the influence of Neuroendocrine Stress on tumor growth and the mechanisms of resistance to anticancer treatments. This research has allowed crucial advances in the understanding of how the tumor microenvironment and neural effects impact the progression of Gynecologic Cancer.

He is the recipient of multiple awards, including the Research Professor Award from the American Cancer Society and the Claudia Cohen Research Foundation Prize for Outstanding Researcher in Gynecologic Cancer. In turn, he has contributed more than 35 book chapters and numerous peer-reviewed scientific publications, as well as filing 11 patents and technology licenses. In short, his work has been instrumental in academia and clinical practice, where he has continued to share his expertise as an invited lecturer and leader in Gynecologic Cancer research.

• Vice Chair of Translational Research at MD Anderson Cancer Center, Texas, United States
• Co-Director of the Center for RNA Interference and Non-Coding RNA at MD Anderson Cancer Center

• Director of the Blanton-Davis Multidisciplinary Ovarian Cancer Research Program

• Co-Director of the Ovarian Cancer Moon Shot Program

• Fellow in Gynecologic Oncology at the University of Iowa Hospitals

• Doctor of Medicine from the University of North Carolina

• Member of: American Society for Clinical Investigation (ASCI), American Association for the Advancement of Science (AAAS) and Association of American Physicians (AAP)